Product Information
ERYTHROMYCIN 500 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $2.5871 per EA under NDC 75834024301. Its NADAC has been published 241 times since Jan 12, 2022.
FDA first approved this application on Jun 28, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834024301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA213628FDA Approved
6/28/2021
TE Code
AB
On Market Since
7/15/2021
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 500 MG TABLET has been published 241 times since Jan 12, 2022, and over the history we have for it it has declined 80.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5871 per EA |
|---|---|
| All-time high | $13.2213 (May 11, 2022) |
| All-time low | $2.0242 (Aug 21, 2024) |
| 52-week high | $3.0014 |
| 52-week low | $2.5871 |
| Median price | $3.9764 |
| Average price | $5.8749 |
| Largest weekly change | +40.9% (Nov 20, 2024) |
| Weeks tracked | 241 |
| Tracking since | Jan 12, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 500 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $2.5871 per EA (NDC 75834024301), effective Aug 19, 2026.
How has the price of ERYTHROMYCIN 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 500 MG TABLET has declined 80.4%. It has been tracked across 241 weekly CMS publications since Jan 12, 2022.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 500 MG TABLET?
Since Jan 12, 2022, the NADAC for ERYTHROMYCIN 500 MG TABLET has ranged from a low of $2.0242 (Aug 21, 2024) to a high of $13.2213 (May 11, 2022), with a median of $3.9764 per EA.
Are there cheaper alternatives to ERYTHROMYCIN 500 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ERYTHROMYCIN 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ERYTHROMYCIN 500 MG TABLET?
ERYTHROMYCIN 500 MG TABLET (NDC 75834024301) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.